Current guidelines recommend regular monitoring of PTH in patients with non-dialysis CKD from CKD stage G3a, in order to identify these individuals, with monitoring intervals based on baseline PTH levels and CKD progression [7]. This evidence concerns the gene PTH and chronic kidney disease.